Creatine ethyl ester arrived in the mid-2000s with a simple pitch: attach an ethyl group to creatine, make it more fat-soluble, and more of it will cross into muscle. The published record is short enough to read in full. It holds one trial that took muscle biopsies, a cluster of chemistry papers from the same year that explain what that trial saw, four case reports from kidney clinics, and one 2026 trial that points the other way. This page reports what each found and reads what US labels declare. It gives no usage guidance.
What the molecule is
Creatine ethyl ester is creatine whose carboxylic acid group has been joined to ethanol. It is normally sold as the hydrochloride salt.
| Molar mass (g/mol) | Creatine it could yield per gram | |
|---|---|---|
| Creatine | 131.13 | 1.00 g |
| Creatine monohydrate | 149.15 | 0.88 g |
| Creatine ethyl ester (free base) | 159.19 | 0.82 g |
| Creatine ethyl ester hydrochloride | 195.65 | 0.67 g |
The right-hand column is a ceiling, MuscleLedger's arithmetic from PubChem molar masses. It assumes every molecule gives up its creatine. The same sum for the other salts is on the guide to every creatine form.
The literature in one count
The PubMed search "creatine ethyl ester"[tiab] returned 20 records on 13 November 2026. Sorted by hand from titles and abstracts:
| Kind of record | Count |
|---|---|
| Controlled trials in people | 4 |
| Open study in patients with a transporter disorder | 1 |
| Case reports of raised creatinine | 4 |
| Laboratory and analytical papers | 9 |
| Reviews | 2 |
Only two of the four controlled trials compare ethyl ester with monohydrate. The third tested thinking tasks against placebo, and the fourth used ethyl ester only as part of a blend.
The biopsy trial
Spillane and colleagues at Baylor University recruited 42 men who did not lift weights; 30 finished, ten in each of three groups: placebo, creatine monohydrate and creatine ethyl ester. All trained with heavy weights for 48 days. Each supplement was given at 0.30 g per kg of fat-free mass for five days (about 20 g a day) and then 0.075 g per kg for 42 days (about 5 g a day). The paper notes that this was twice the loading amount then recommended for ethyl ester.
| Measure | What the full text reports |
|---|---|
| Serum creatine | Higher on monohydrate than on placebo (p = 0.007) and than on ethyl ester (p = 0.005) |
| Serum creatinine | Higher on ethyl ester than on placebo and monohydrate (both p = 0.001). Ethyl ester group: 0.95 mg/dL at baseline, 2.68 mg/dL at day 6, still raised at days 27 and 48. The monohydrate group stayed inside the paper's normal range of 0.8 to 1.3 mg/dL |
| Total muscle creatine | Higher than placebo on monohydrate (p = 0.026) and on ethyl ester (p = 0.041); no difference between the two. Monohydrate rose by day 6, ethyl ester only by day 27 |
| Strength, power, body mass, fat-free mass, thigh muscle, body water | Changed with training; no difference between any groups |
Two things about this trial deserve stating. First, with ten untrained men per group, even monohydrate did not separate from placebo on strength, so the trial could not have shown a strength advantage for either form; its informative results are the blood and muscle measurements. Second, the ethyl ester capsules came from Labrada Nutritionals, a company that sold the ingredient. The acknowledgements record supplement donations from Labrada and from AST Sport Science, which supplied the placebo, and the authors declare no financial interest. A result this unfavourable from a seller's donated product is harder to dismiss than one from a rival.
The authors' conclusion: ethyl ester "was not as effective at increasing serum and muscle creatine levels" as monohydrate.
Why the creatinine rose: the chemistry
Three laboratory papers published within months of the trial describe what happens to the ester in water.
- Giese and Lecher, 2009 incubated creatine ethyl ester at 37 °C in water and in buffered saline. It closed into a ring to give creatinine "as the exclusive product", and the change became "nearly instantaneous as the pH approaches 7.4", the pH of blood. They called it "a pronutrient for creatinine rather than creatine".
- Giese and Lecher, 2009, second paper added 1.5 mg to reconstituted human plasma for four hours. Conversion to creatine by plasma enzymes "was not observed to any detectable extent", and the only species found afterwards was creatinine. The authors describe this as not a definitive account of what happens in the body.
- Katseres and colleagues, 2009 measured the rate of breakdown from pH 1.6 to 7.0 and estimated a half-life in blood "on the order of one minute", too short to reach muscle as the ester.
The counterpoint comes from Gufford and colleagues, 2013. They confirmed the ring closure and that it speeds up with pH: a half-life of 570 hours at pH 1.0 and 23 seconds above pH 8.0. But they also found the ester crossed a layer of human gut cells faster than creatine or creatinine, and concluded that its stability in stomach acid plus that permeability gave it "potential for improved oral absorption". That is a laboratory argument for absorption of the intact ester. It does not address what the ester becomes once it is in blood at pH 7.4, where their own figures and the 2009 papers agree it is short-lived.
Nobody has published the experiment that would settle it: a study in people that tracks the ester, creatine and creatinine in blood after a dose. The 2009 plasma paper asked for exactly that.
The four case reports
Creatinine is the blood marker most estimates of kidney function are built on, so a supplement that is converted into creatinine can make healthy kidneys look as if they are failing. Four reports describe this.
| Report | What happened |
|---|---|
| Velema and de Ronde, 2011 | Serum creatinine raised in a creatine ethyl ester user; normal one week after stopping |
| van der Meijden and Smak Gregoor, 2013 | A 54-year-old woman referred for a falling estimated filtration rate; no abnormality found; the estimate normalised after she stopped creatine supplements. The authors name creatine ethyl ester among products that can do this |
| Williamson and New, 2014 | Blood results resembling advanced kidney failure in a creatine ethyl ester user; reversed on stopping; kidney function judged normal |
| Law and colleagues, 2019 | A kidney transplant recipient whose creatinine rose on creatine ethyl ester but not on monohydrate; ultrasound and biopsy of the graft were normal; creatinine normalised on stopping |
These are single patients, and a case report cannot say how often something happens. What they add is consistency with the trial: the day-6 figure of 2.68 mg/dL in healthy young men is the same phenomenon measured in a group. They do not show kidney damage. They show a misleading test, which carries its own cost: the 2019 patient underwent a biopsy of a transplanted kidney. How creatine of any form shows up in routine results is covered on the page about creatine and creatinine in bloodwork, and the question of actual harm on creatine and kidney function. Anyone with a kidney condition or an abnormal result has a clinician's question, not a supplement question.
The 2026 trial that points the other way
Duan, Wang and Wang randomised 40 collegiate male soccer players to monohydrate, ethyl ester, hydrochloride or placebo, ten per group, for four weeks of repeated-sprint training three times a week. Every creatine group took 5 g a day with no loading phase. All three creatine groups improved more than placebo on jump, 20-metre sprint, an agility run, peak power and fatigue index, and the abstract reports that ethyl ester and hydrochloride "showed superior gains (p < 0.05)" over monohydrate on physical performance and peak power.
It is the only published trial in which ethyl ester beat monohydrate, and its limits are stated in its own text. The same 5 g was used for every form, so, in the authors' words, "the exact amount of elemental creatine consumed was not identical across groups": by the table above the ethyl ester group received less creatine than the monohydrate group, which makes the result harder to explain, not easier. The outcomes were performance tests. With ten players per group and no replication, it sits against a biopsy trial and three chemistry papers that give a reason for the opposite result. The hydrochloride half of the same trial is discussed on monohydrate versus HCl.
The other human studies
- Ling and colleagues, 2009 gave creatine ethyl ester or placebo before five thinking tasks and reported improvement "on several measures". The abstract gives neither the number of people nor the amount, and the authors ask for replication "using objective measures of compliance".
- Korovljev and colleagues, 2026 included an 800 mg a day blend of creatine hydrochloride and ethyl ester as one of four arms in 36 perimenopausal and menopausal women. The significant findings in the abstract belong to the 1,500 mg hydrochloride arm.
- Fons and colleagues, 2010 gave creatine ethyl ester for a year to four patients with creatine transporter deficiency, hoping a fat-soluble form would bypass the missing transporter. Brain creatine did not rise and the treatment was stopped.
What 44 labels declare
The NIH Dietary Supplement Label Database returned 93 labels for the phrase on 13 November 2026. 78 list creatine ethyl ester as an ingredient; 44 are flagged as on the market and 34 as off it.
| Reading of the 78 labels | Count |
|---|---|
| Entered into the database 2011–2015 | 54 |
| Entered 2016–2020 | 13 |
| Entered 2021–2024 | 11 |
| Reading of the 44 on-market labels | Count |
|---|---|
| State an amount of creatine ethyl ester per serving | 18 |
| Hold it inside a blend with no amount given, or record none | 26 |
| List more than ten ingredients | 27 |
| Lowest and highest stated amount per serving | 260 mg · 4 g |
| Of the 18 with a figure: about half a gram or less | 5 |
| Of the 18 with a figure: 1.5 g to 2.25 g | 6 |
| Of the 18 with a figure: 3 g to 4 g | 7 |
Three things stand out. The category is small and old. Forty-four on-market labels compares with 249 for creatine nitrate on this site's count of 11 November, and more than two-thirds of all ethyl ester labels entered the database by 2015. The database's on-market flag is not a live shelf check, so some of the 44 may no longer be sold.
Stated servings sit at or below what the trial gave in a day. The highest stated serving is 4 g, on a tablet label that does not name the salt: at most 3.3 g of creatine, or 2.7 g if it is the hydrochloride. Five labels, all multi-creatine blends, state about half a gram or less. The biopsy trial gave roughly 5 g a day in its maintenance phase and still saw no advantage. Servings per day on each label were not tallied for this count.
The absorption claim is still printed. A label entered in December 2024 describes the ingredient as a form with "a higher absorption rate". A 2012 entry from Labrada, the company whose ethyl ester was used in the 2009 trial, describes it as "designed to rapidly penetrate the lipid membranes of muscle cells". That label carries a 2009 copyright line, the year the trial was published.
Seven of the 44 on-market labels belong to one brand's product line, and four each to three other brands. This is a count of labels, not of sales.
What is established, and what is not
- Established: at about 20 g then 5 g a day, creatine ethyl ester raised serum creatinine roughly threefold in healthy young men and did not raise serum creatine as monohydrate did.
- Established: in the one biopsy comparison it showed no advantage over monohydrate in muscle creatine, strength, power or body composition.
- Established in the laboratory: in water near the pH of blood the ester converts to creatinine within seconds to minutes; in strong acid it is stable for hours.
- Reported in single patients: misleading kidney blood tests that reversed on stopping.
- Not established: that any amount of creatine ethyl ester builds more muscle creatine than the same amount of monohydrate. The single contrary performance trial measured no creatine.
- Not tested: what fraction of a swallowed dose reaches human blood as creatine, as the ester or as creatinine; any trial matched on creatine content; any comparison with monohydrate longer than seven weeks; women in a head-to-head comparison.
The same question for the other alternative forms is answered on creatine HCl, Kre-Alkalyn and creatine nitrate. Ethyl ester is the one case among them where a head-to-head trial found the alternative doing measurably worse on a blood marker.
How this page was put together
The PubMed count is the search "creatine ethyl ester"[tiab] run on 13 November 2026, with all 20 records sorted from their titles and abstracts; one analytical paper on urine crystals was classed as laboratory work from its title alone. The 2009 biopsy trial and the 2026 soccer trial were read in open-access full text, including methods, acknowledgements and limitations; the 2009 abstract and full text describe the serum creatine comparison differently, and this page follows the full text and its figure legend. The other papers were read as abstracts. The label census is the Dietary Supplement Label Database API (v9): the phrase search, filtered to records whose ingredient list names creatine ethyl ester, then each on-market label's ingredient rows and statements read for the declared amount. Labels were entered between 2011 and 2024 and a product may have been reformulated or withdrawn since. The mass arithmetic uses PubChem molar masses. MuscleLedger did not test any product (how we work).
Sources
- Spillane M, Schoch R, Cooke M, et al. The effects of creatine ethyl ester supplementation combined with heavy resistance training on body composition, muscle performance, and serum and muscle creatine levels. J Int Soc Sports Nutr 2009;6:6. PMID 19228401 · full text (read 2026-11-13).
- Giese MW, Lecher CS. Non-enzymatic cyclization of creatine ethyl ester to creatinine. Biochem Biophys Res Commun 2009;388:252–5. PMID 19660433 (abstract).
- Giese MW, Lecher CS. Qualitative in vitro NMR analysis of creatine ethyl ester pronutrient in human plasma. Int J Sports Med 2009;30:766–70. PMID 19585404 (abstract).
- Katseres NS, Reading DW, Shayya L, et al. Non-enzymatic hydrolysis of creatine ethyl ester. Biochem Biophys Res Commun 2009;386:363–7. PMID 19524547 (abstract).
- Gufford BT, Ezell EL, Robinson DH, et al. pH-dependent stability of creatine ethyl ester: relevance to oral absorption. J Diet Suppl 2013;10:241–51. PMID 23957855 (abstract).
- Duan C, Wang Z, Wang Q. Creatine formulations and repeated sprint training. J Int Soc Sports Nutr 2026;23(sup1):2721147. PMID 42720250 · full text (read 2026-11-13).
- Velema MS, de Ronde W. Elevated plasma creatinine due to creatine ethyl ester use. Neth J Med 2011;69:79–81. PMID 21411845 (abstract).
- van der Meijden WA, Smak Gregoor PJ. Impaired renal function: be aware of exogenous factors. Ned Tijdschr Geneeskd 2013;157:A5944. PMID 23759178 (English abstract).
- Williamson L, New D. How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology. BMJ Case Rep 2014. PMID 25239988 (abstract).
- Law JP, Di Gerlando S, Pankhurst T, Kamesh L. Elevation of serum creatinine in a renal transplant patient following oral creatine supplementation. Clin Kidney J 2019;12:600–601. PMID 31384454 (abstract).
- Ling J, Kritikos M, Tiplady B. Cognitive effects of creatine ethyl ester supplementation. Behav Pharmacol 2009;20:673–9. PMID 19773644 (abstract).
- Korovljev D, Ostojic J, Panic J, et al. CONCRET-MENOPA. J Am Nutr Assoc 2026;45:199–210. PMID 40854087 (abstract).
- Fons C, Arias A, Sempere A, et al. Response to creatine analogs in fibroblasts and patients with creatine transporter deficiency. Mol Genet Metab 2010;99:296–9. PMID 19955008 (abstract).
- NIH Office of Dietary Supplements, Dietary Supplement Label Database, API v9, search "creatine ethyl ester" and 44 individual label records, read 2026-11-13; labels 319479 and 4823.
- PubChem, read 2026-11-13: creatine CID 586 (131.13 g/mol); creatine ethyl ester CID 10197817 (159.19); creatine ethyl ester hydrochloride CID 25114309 (195.65). Creatine monohydrate 149.15 as read for this site's forms page on 2026-09-24.
- PubMed search
"creatine ethyl ester"[tiab], 2026-11-13: 20 records.
